Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)

NCT02981758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-02-11

No results posted yet for this study

Summary

A comparison of reported estimated blood loss with quantified blood loss in all patients whose medical records indicate Triton was used during their vaginal delivery.

Conditions

  • Post-partum Hemorrhage (PPH)

Sponsors & Collaborators

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • Andrew Rubenstein, M.D. · Hackensack Meridian Health

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-31
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02981758 on ClinicalTrials.gov